American Clinical Laboratory Association This Laboratory Professionals Week, we’re taking a moment to thank laboratory researchers, technicians, administrative staff and medical officers who are going above and beyond the call of duty to serve patients during the COVID-19 pandemic. Today, ACLA is featuring BioReference’s Chief Medical Officer and laboratory director who has played a critical […]
Search Results for: MG
Dr. Oz Jon Cohen, the executive chairman of Bioreference Laboratories, joins via Zoom, and shares an update on the progress of COVID-19 testing in New York. Plus, he details the specific requirements of drive-thru testing. Click here for original post on Dr. Oz
The Associated Press ALBANY, N.Y. (AP) — New York state opened its first drive-through coronavirus testing center Friday in hard-hit New Rochelle, aiming to break a testing bottleneck that Gov. Andrew Cuomo called a crisis. The six-lane testing center will soon handle 500 people a day, with priority given to residents of the New York […]
South Florida Business Journal BioReference Laboratories, a subsidiary of Miami-based Opko Health (Nasdaq: OPK), has begun accepting specimen from health care providers throughout the U.S. to test whether or not their patients have COVID-19. The lab launched testing Friday, expecting to start with about 1,000 to 2,000 tests a day. BioReference expects to eventually ramp […]
Medicare coverage for patients meeting certain criteria to begin as of December 30, 2019 MIAMI, Nov. 15, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (OPK) today announced that Novitas Solutions, Inc. has issued its final Local Coverage Determination (LCD) for Medicare payments for the 4Kscore® test with defined coverage criteria, effective December 30, 2019. Full text of the […]
Proposed LCD will allow Medicare coverage within criteria for the 4Kscore® Test MIAMI, June 28, 2019 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a new proposed local coverage determination (LCD) for the 4Kscore® test, with defined coverage criteria. Under the LCD, Medicare will reimburse the test for patients who […]
BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV).